symptoms of khat quitters
Dr. Rashad Muhammad Al-Senussi, a consultant psychiatrist and director of the Psychotropic Research Center at Jizan University, revealed yesterday to Al-Iqtisadiah that the drug that will be tested on "khat" users is a drug found in the market called "Wellpetrin" and it is used originally to reduce the effects resulting from quitting smoking and will be used For those who want to quit using khat. Al-Senussi said that the drug will be tested on those wishing to quit khat in the middle of next year, with joint cooperation between the University of Jizan, the World Association of Addiction Medicine in the Swiss capital (Geneva), and a doctor from the University of California. He pointed out that the results of the research and experiments conducted by the Psychotropic Research Center at Jizan University on 50 people who wanted to quit taking "khat" showed the psychological, nervous and health status that the user suffers, explaining that this study extended over a year to different age groups. The motives for the use of "khat" and put some observations that appeared on the sample, indicating that most of those who left "khat" said that they suffered from withdrawal symptoms and experienced fatigue, fatigue, lethargy, and a feeling of sleep. These effects extended between one and two weeks, and they mentioned that those who do not have persistence will return during these days. The period of what makes the center work, what can relieve these symptoms, and give activity and vitality during the withdrawal period that can prevent the abuser from relapse. Al-Senussi pointed out that the specialists were unanimously agreed on the use of a drug that is used with people who quit smoking. One of its qualities is to alleviate the withdrawal symptoms felt by those who quit from "khat" and give them vigor and vitality. He added that the study saw the experience of possible drugs and other stimuli that would treat sleep and lethargy that may afflict those who quit the use, indicating that the experiment will be applied for a whole year to be evaluated in cooperation with partners, where it will be generalized if it achieves positive results. He expected that the experience would help those who wish to give up this habit, provided there is a sincere desire for the person who consumes khat. He emphasized that addiction in general is a major health problem through its relationship with other risky behaviors and disorders, indicating that the Research Center aims to provide scientific and objective information that will support making informed decisions on issues of abuse of psychotropic substances, pointing out that the center includes researchers from all The university''s medical and health faculties support research that seeks to identify factors that put people at risk of increased abuse of psychotropic substances. It is noteworthy that Jazan University presented a working paper at the World Conference held at the headquarters of the World Association of Addiction Medicine in the Swiss capital, Geneva, on its research project entitled "The experience of discontinuation from khat ... its causes and effects", in which it summarized the results of research and experiments carried out by the Psychotropic Research Center, and the paper included A presentation of the reasons for their discontinuation from consuming qat and the effects of that on them and their families and ways to benefit from the results of this research to motivate those who wish to stop consuming the khat plant, as the research is the first of its kind in the world in this field, and resulted in the adoption of a research project that will introduce a new drug to help those who wish to Treating the withdrawal symptoms experienced by the consumption of the khat plant during the first weeks of taking it off.
